BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36595779)

  • 21. Comparison of transcatheter arterial chemoembolization combined with radiofrequency ablation or microwave ablation for the treatment of unresectable hepatocellular carcinoma: a systemic review and meta-analysis.
    Zhao J; Wu J; He M; Cao M; Lei J; Luo H; Yi F; Ding J; Wei Y; Zhang W
    Int J Hyperthermia; 2020; 37(1):624-633. PubMed ID: 32525724
    [No Abstract]   [Full Text] [Related]  

  • 22. Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma.
    Gaia S; Ciruolo M; Ribaldone DG; Rolle E; Migliore E; Mosso E; Vola S; Risso A; Fagoonee S; Saracco GM; Carucci P
    Curr Oncol; 2021 Feb; 28(2):1034-1044. PubMed ID: 33669107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microwave ablation determines similar survival outcomes as compared to radiofrequency ablation for the treatment of hepatocellular carcinoma.
    Khan A; Mostowy M; Owusu M; Mutambanengwe M; Habimana S; Bence S; Facciorusso A
    Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):829-833. PubMed ID: 33356655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial.
    Radosevic A; Quesada R; Serlavos C; Sánchez J; Zugazaga A; Sierra A; Coll S; Busto M; Aguilar G; Flores D; Arce J; Maiques JM; Garcia-Retortillo M; Carrion JA; Visa L; Villamonte M; Pueyo E; Berjano E; Trujillo M; Sánchez-Velázquez P; Grande L; Burdio F
    Sci Rep; 2022 Jan; 12(1):316. PubMed ID: 35013377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency versus microwave ablation for hepatocellular carcinoma within the Milan criteria in challenging locations: a retrospective controlled study.
    Han X; Ni JY; Li SL; Deng HX; Liang HM; Xu YY; Huang ZM; Zhang TQ; Huang JH
    Abdom Radiol (NY); 2021 Aug; 46(8):3758-3771. PubMed ID: 34032898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
    Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study.
    Wang X; Yu H; Zhao F; Xu Y; Wang C; Liu K; Liu B; Zheng H; Wei Y; Wang X; Zhu Q; Huang M; Feng Y
    Eur J Radiol; 2023 Jul; 164():110860. PubMed ID: 37178491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microwave ablation compared with radiofrequency ablation for treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis.
    Glassberg MB; Ghosh S; Clymer JW; Qadeer RA; Ferko NC; Sadeghirad B; Wright GW; Amaral JF
    Onco Targets Ther; 2019; 12():6407-6438. PubMed ID: 31496742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: A retrospective comparative study.
    Lee KF; Wong J; Hui JW; Cheung YS; Chong CC; Fong AK; Yu SC; Lai PB
    Asian J Surg; 2017 Jul; 40(4):301-308. PubMed ID: 26922631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of microwave ablation and radiofrequency ablation in the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Dou Z; Lu F; Ren L; Song X; Li B; Li X
    Medicine (Baltimore); 2022 Jul; 101(30):e29321. PubMed ID: 35905207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
    Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
    Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of MWA versus RFA and CA for renal tumors: A systematic review and meta-analysis of comparison studies.
    Castellana R; Natrella M; Fanelli G; Lancellotta V; Cornacchione P; Castellana M; Filippiadis D; Tagliaferri L; Iezzi R
    Eur J Radiol; 2023 Aug; 165():110943. PubMed ID: 37392547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microwave ablation versus radiofrequency ablation for treating spinal metastases.
    Yao Y; Zhu X; Zhang N; Wang P; Liu Z; Chen Y; Xu C; Ouyang T; Meng W
    Medicine (Baltimore); 2023 Jun; 102(25):e34092. PubMed ID: 37352076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis.
    Feng Y; Wang L; Lv H; Shi T; Xu C; Zheng H; Qi J; Zhao X; Li J; Gao Y; Qin C; Zhu Q
    HPB (Oxford); 2021 Apr; 23(4):512-519. PubMed ID: 32839089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Laparoscopic Microwave to Radiofrequency Ablation of Small Hepatocellular Carcinoma (≤3 cm).
    Santambrogio R; Chiang J; Barabino M; Meloni FM; Bertolini E; Melchiorre F; Opocher E
    Ann Surg Oncol; 2017 Jan; 24(1):257-263. PubMed ID: 27581608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of laparoscopic liver resection versus radiofrequency ablation in patients with early and small hepatocellular carcinoma: an updated meta-analysis and meta-regression of observational studies.
    Shaaban Abdelgalil M; Amer BE; Yasen N; El-Samahy M; Awad AK; Elfakharany B; Saeed O; Abd-ElGawad M
    World J Surg Oncol; 2024 Feb; 22(1):47. PubMed ID: 38326841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of percutaneous microwave ablation with radiofrequency ablation for hepatocellular carcinoma adjacent to major vessels: A retrospective study.
    Shen Q; Wang N; Wu PP; Tan BB; Qian GJ
    J Cancer Res Ther; 2022 Apr; 18(2):329-335. PubMed ID: 35645097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
    Yuan P; Zhang Z; Kuai J
    J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of combined transarterial chemoembolization and ablations in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Keshavarz P; Raman SS
    Abdom Radiol (NY); 2022 Mar; 47(3):1009-1023. PubMed ID: 34982183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microwave ablation compared with hepatic resection for the treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis.
    Glassberg MB; Ghosh S; Clymer JW; Wright GWJ; Ferko N; Amaral JF
    World J Surg Oncol; 2019 Jun; 17(1):98. PubMed ID: 31182102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.